Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid Federal government would pick up about three-fourths of the cost for Medicaid coverage Nov 26, 2024
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome News and commentary from the endocrinology world Nov 26, 2024
Are GLP-1 Drugs Putting an End to Bariatric Surgery? A conversation with bariatric surgeon Christine J. Ren-Fielding, MD Nov 26, 2024
Many Drinkers Cut Back After Starting Obesity Meds, Study Finds In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
Philly's Tax on Sugary Drinks Did Not Trim Kids' Obesity "Weight is multifactorial," researcher noted Nov 25, 2024
Even With Access to Blockbuster Obesity Drugs, Some People Don't Lose Weight "It's discouraging," says one patient Nov 25, 2024
'A Watershed Moment': GLP-1 Drug Succeeds in Late-Stage MASH Trial First positive phase III study for a GLP-1 agonist in chronic liver disease Nov 20, 2024
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
Metformin Use Linked to Fewer Asthma Attacks Addition of GLP-1 drugs led to an even greater reduction Nov 19, 2024
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data? News and commentary from the endocrinology world Nov 19, 2024
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy Most are eligible for weight management indication Nov 18, 2024
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge News and commentary from the endocrinology world Nov 12, 2024
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs Nov 11, 2024
Patients With Obesity Shed Pounds With Drug-Free Capsule Participants also had improved cardiometabolic measures with Epitomee device Nov 08, 2024
Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer Health news and commentary gathered by 51˶ staff Nov 08, 2024
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Counter-Marketing Messages Reduced Intent to Drink Sugary Beverages Messages about unethical industry practices came with less perceived weight stigma Nov 06, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down News and commentary from the endocrinology world Nov 05, 2024
Weight Loss After Bariatric Surgery in Teens Persisted at 10 Years Remission of coexisting conditions was also maintained, long-term data show Oct 30, 2024
Wegovy Reduced Pain From Knee Osteoarthritis Patients taking the GLP-1 drug also had greater improvement in physical function Oct 30, 2024
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD However, 24 weeks of the GLP-1 had no impact on eGFR Oct 29, 2024
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids GLP-1 receptor agonists may have better protective benefits versus metformin, insulin Oct 24, 2024
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients Findings leave researcher "concerned" Oct 23, 2024
Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids News and commentary from the endocrinology world Oct 22, 2024
No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonists Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files Suit Health news and commentary gathered by 51˶ staff Oct 22, 2024
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer News and commentary from the endocrinology world Oct 15, 2024
Want to Cut Urate Levels? Try Losing Weight But Japanese study suggests losses need to be substantial Oct 15, 2024
Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonists GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions Oct 14, 2024
Do Lipid Values in Adolescence Improve CVD Risk Prediction? Including lipids did not prove superior to non-laboratory-based criteria alone, study finds Oct 14, 2024
Type 2 Diabetes Diagnoses Emerge in Teens Months After COVID Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia News and commentary from the endocrinology world Oct 08, 2024
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved? I anticipate benefits outweighing potential risks in only a select few situations Oct 06, 2024
Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equation Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
